1008139-25-0 Usage
General Description
Isoxazol-4-ylboronic acid is a specialized chemical compound that has the molecular formula C4H5BO3, and is also known as 4-Isoxazolylboronic acid. The chemical, which falls under the category of boronic acids, is commonly used in scientific research, particularly in the field of medicinal and organic chemistry for the synthesis of complex molecules. It is generally available in a fine crystalline powder form that is typically beige or off-white in colour. Handling or exposure to Isoxazol-4-ylboronic acid should be conducted with caution as the chemical is considered hazardous and can cause eye and skin irritation.
Check Digit Verification of cas no
The CAS Registry Mumber 1008139-25-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,8,1,3 and 9 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1008139-25:
(9*1)+(8*0)+(7*0)+(6*8)+(5*1)+(4*3)+(3*9)+(2*2)+(1*5)=110
110 % 10 = 0
So 1008139-25-0 is a valid CAS Registry Number.
1008139-25-0Relevant articles and documents
Generation of an 4-Isoxazolyl Anion Species: Facile Access to Multifunctionalized Isoxazoles
Morita, Taiki,Fuse, Shinichiro,Nakamura, Hiroyuki
supporting information, p. 13580 - 13584 (2016/10/21)
A direct functionalization of unsubstituted isoxazole (1) was achieved by generation of 4-isoxazolyl anion species (3). An efficient 4-iodination of isoxazole and halogen–metal exchange reaction using a turbo Grignard reagent (iPrMgCl? LiCl) were essentia
ORGANIC COMPOUNDS
-
Page/Page column 144-145, (2009/09/04)
Compounds of formula (I) in free or salt or solvate form, where T1, T2, X, Ra, Rb, R8 and R9 have the meanings as indicated in the specification, are useful for treating inflammatory or obstructive airways, pulmonary hypertension, pulmonary fibrosis, liver fibrosis, muscle diseases and systemic skeletal disorders. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
